Archive for the ‘Advocacy Center-Alzheimer’s & DS’ Category

National Coverage Determination May Limit Access to AD Treatment

March 14th, 2022 by Global Down Syndrome Foundation

Medicare Proposal on Alzheimer’s Drug Draws Criticism From Drugmakers

February 23rd, 2022 by Global Down Syndrome Foundation

Biogen Alzheimer’s Drug Coverage Threatens Minorities’ Access

January 13th, 2022 by Global Down Syndrome Foundation

Medicare limits coverage of $28,000-a-year Alzheimer’s drug

January 12th, 2022 by Global Down Syndrome Foundation